Stocks Health care GERN
NASDAQ · Health careGeron Corp (GERN)
It posted a net loss of $47.8M. At September 30, 2026 it held $69.2M in cash against $120.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about Geron Corp
- Net worth
- Geron Corp has a market value (market cap) of $633.3M at the latest share price, and shareholders' equity of $226.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2023 revenue was $237K (-60.2% year on year), with a net loss of $184.1M.
- Cash flow
- In fiscal 2025 operations used $111M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Geron Corp's next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Geron Corp does
Geron Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GERN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$83.5M | -$0.13 | n/a |
| 2024 | n/a | -$174.6M | -$0.27 | -$219.3M |
| 2023 | $237K | -$184.1M | -$0.32 | -$168.6M |
| 2022 | $596K | -$141.9M | -$0.37 | -$127.8M |
| 2021 | $1.4M | -$116.1M | -$0.35 | -$95.8M |
| 2020 | $253K | -$75.6M | -$0.28 | -$67.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Geron Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 27% to $60.2M versus the same quarter last year; diluted EPS $0.00 versus -$0.03.
- November 4, 2026
- October 28, 2026Other event 8-K
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- August 6, 2026
- August 5, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 17% to $57.5M versus the same quarter last year; diluted EPS -$0.02 versus -$0.02.
- May 27, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Geron Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 30, 2026 | Spiegel Robert J.Director | Received as pay | 6,351 | $7.8K |
| June 30, 2026 | Spiegel Robert J.Director | Received as pay | 6,103 | $7.8K |
| March 31, 2026 | Spiegel Robert J.Director | Received as pay | 5,243 | $7.8K |
| February 18, 2026 | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | Exercised options | 27,500 | - |
| February 18, 2026 | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | Sold | 9,855 | $19.1K |
| December 31, 2025 | Spiegel Robert J.Director | Received as pay | 5,918 | $7.8K |
Who owns GERN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| RA Capital Management, L.P.13G, passive with 3 related filers | 9.9% | August 14, 2026 |
| Soleus Capital Master Fund, L.P.13G, passive with 5 related filers | 6.5% | May 8, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 260 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 49,115,571 | +1,795,792 |
| RA Capital Management, L.P. | 42,809,751 | -20,961,615 |
| Soleus Capital Management, L.P. | 42,808,659 | +1,300,000 |
| State Street Corp | 35,856,671 | +5,359,488 |
| Citadel Advisors LLC | 29,038,928 | +7,462,359 |
| Vanguard Capital Management LLC | 27,250,215 | +581,186 |
| Nantahala Capital Management, LLC | 24,450,000 | +13,225,000 |
| Clearbridge Investments, LLC | 19,648,853 | +28,533 |
| Eversept Partners, LP | 18,717,422 | -117,461 |
| Goldman Sachs Group Inc | 16,633,368 | +5,456,777 |
| Geode Capital Management, LLC | 14,555,954 | +885,169 |
| Morgan Stanley | 12,945,431 | +280,312 |
| Vanguard Portfolio Management LLC | 10,812,598 | +6,143,815 |
| Vivo Capital, LLC | 8,671,797 | 0 |
| Millennium Management LLC | 8,112,267 | +790,745 |
| Kynam Capital Management, LP | 6,836,318 | 0 |
| Candriam S.C.A. | 5,589,182 | +1,667,706 |
| Fmr LLC | 5,502,807 | -1,094,349 |
| Pale Fire Capital SE | 5,307,204 | +418,900 |
| Northern Trust Corp | 5,032,212 | +169,948 |
Insiders
2 insiders reported holding 229,806 shares in total, about $226.5K at the last price.
| Holder | Shares |
|---|---|
| Spiegel Robert J.Director | 212,161 |
| Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | 17,645 |
Questions about GERN
What does Geron Corp do?
Geron Corp is a company in the Health care sector, listed on NASDAQ as GERN. Its shares trade on NASDAQ under the ticker GERN.
What is Geron Corp's net worth?
Geron Corp has a market value (market cap) of $633.3M at the latest share price, and shareholders' equity of $226.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Geron Corp profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $47.8M.
When did Geron Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026.
When is Geron Corp's next earnings report?
Geron Corp's next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare GERN with
Follow GERN
Get an email when Geron Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Geron Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.